Skip to main content
. 2014 Apr;58(4):2156–2166. doi: 10.1128/AAC.01350-13

FIG 1.

FIG 1

Structures of Galf derivatives evaluated against Leishmania. (A) Octyl-β-d-galactofuranoside/compound 1; (B) 6-amino-galactofuranoside/compound 2; (C) 6-N-acetamido-β-d-galactofuranoside/compound 3; (D) 6-azido-galactofuranoside/compound 4; control compounds, like (E) octyl-β-d-galactopyranoside/compound 5; and (F) octanol/compound 6.